Pharma Friday – Sept. 11, 2026
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Moonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Cardiometabolic Diseases On Sept. 8, Moonwalk Biosciences, a biotechnology company developing adipose-targeted RNA interference (RNAi) medicines for obesity and cardiometabolic diseases, announced the closing of […]
The post Pharma Friday – Sept. 11, 2026 appeared first on Endocrine News.
Apa Reaksi Anda?
Suka
0
Kurang Suka
0
Setuju
0
Tidak Setuju
0
Bagus
0
Berguna
0
Hebat
0
